Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eucrates Biomedical Acqui...

    NASDAQ: EUCRU · Real-Time Price · USD
    10.02
    -0.07 (-0.69%)
    At close: Apr 26, 2023, 9:59 PM

    Eucrates Biomedical Acquisition Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -698K -928K -1.02M -1.01M -1M -500.41K -240.41K -116.41K
    Interest Income
    		 701.13K 383.93K 168.69K 39.49K n/a 28.11K 20.91K 13.68K
    Pretax Income
    		 2.42M 3.48M 3.91M 4.1M 4.77M 3.58M 2.63M 2M
    Net Income
    		 5.44M 7.79M 7.53M 7.25M 6.47M 3.58M 2.63M 2M
    Selling & General & Admin
    		 537.03K 778.15K 1.04M 1.02M 1.02M 509.63K 249.77K 125.35K
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 160.35K 165.67K -1.2K n/a n/a 8.59K 8.59K 8.59K
    Operating Expenses
    		 698.58K 945.02K 1.04M 1.02M 1.02M 518.23K 258.37K 133.94K
    Interest Expense
    		 n/a -1.69M -1.69M -1.69M -1.69M 7.21K n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 698.58K 945.02K 1.04M 1.02M 1.02M 518.23K 258.37K 133.94K
    Income Tax Expense
    		 -3.02M -4.31M -3.62M -3.15M -1.69M n/a n/a n/a
    Shares Outstanding (Basic)
    		 2.98M 10.48M 10.48M 2.98M 4.21M 2.98M 4.21M 4.41M
    Shares Outstanding (Diluted)
    		 2.98M 13.46M 13.46M 13.46M 13.46M 13.46M 13.46M 13.46M
    EPS (Basic)
    		 0.93 1.44 1.59 1.60 1.61 0.92 0.60 0.45
    EPS (Diluted)
    		 0.55 0.58 0.56 0.54 0.48 0.27 0.20 0.15
    EBITDA
    		 -2.58M -1.35M 116.43K 1.32M 4.78M 3.59M 2.63M 2M
    EBIT
    		 -602.92K -832.92K 291.51K 209.43K 215.43K 708.43K -249K -125K
    Depreciation & Amortization
    		 -1.88M -421K 1.14M 2.33M 5.78M 4.15M 2.93M 2.17M

    Add to Watchlist